Cargando…

Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma

SIMPLE SUMMARY: The combination of atezolizumab and bevacizumab was introduced as a first-line therapy for patients with unresectable hepatocellular carcinoma in 2020. Although some patients have shown a treatment response, there have also been those with disease progression. Such cases should be ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanabe, Norikazu, Saeki, Issei, Aibe, Yuki, Matsuda, Takashi, Hanazono, Tadasuke, Nishi, Maiko, Hidaka, Isao, Kuwashiro, Shinya, Shiratsuki, Shogo, Matsuura, Keiji, Egusa, Maho, Nishiyama, Natsuko, Fujioka, Tsuyoshi, Kawamoto, Daiki, Sasaki, Ryo, Nishimura, Tatsuro, Oono, Takashi, Hisanaga, Takuro, Matsumoto, Toshihiko, Ishikawa, Tsuyoshi, Yamasaki, Takahiro, Takami, Taro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251947/ https://www.ncbi.nlm.nih.gov/pubmed/37296889 http://dx.doi.org/10.3390/cancers15112927

Ejemplares similares

Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment
por: Saeki, Issei, et al.
Publicado: (2020)

A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2019)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2019)

Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2020)

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
por: Saeki, Issei, et al.
Publicado: (2018)

Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case Report
por: Iwamoto, Takuya, et al.
Publicado: (2019)

A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy
por: Saeki, Issei, et al.
Publicado: (2015)

EUS-guided biliary drainage in a patient after postcholecystectomy complete biliary transection (with video)
por: Suehiro, Harumi, et al.
Publicado: (2022)

Drastic Improvement in Hepatitis B/C Virus-induced Decompensated Liver Cirrhosis Treated by Total Management Consisting of Interventional Radiology, Endoscopy, and Pharmacotherapy
por: Nishimura, Tatsuro, et al.
Publicado: (2022)

Atezolizumab-induced bilateral anterior uveitis: A case report
por: Mito, Tsuyoshi, et al.
Publicado: (2021)

A case of PD-L1 negative advanced pulmonary sarcomatoid carcinoma effectively treated with atezolizumab, carboplatin, paclitaxel, and bevacizumab
por: Sawatari, Kosuke, et al.
Publicado: (2022)

A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow–derived cells
por: Matsuda, Takashi, et al.
Publicado: (2017)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

Conversion to Curative Resection and Pathological Complete Response Following Targeted Therapies With Atezolizumab and Bevacizumab for Initially Unresectable Hepatocellular Carcinoma: A Case Report
por: Matsuoka, Taisuke, et al.
Publicado: (2023)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
por: Nishimura, Tatsuro, et al.
Publicado: (2019)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Niizeki, Takashi, et al.
Publicado: (2022)

Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment
por: Tamura, Yosuke, et al.
Publicado: (2023)

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
por: Yano, Yoshihiko, et al.
Publicado: (2023)

Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies
por: Watanabe, Shohei, et al.
Publicado: (2021)

Epidermal growth factor receptor expression in canine transitional cell carcinoma
por: HANAZONO, Kiwamu, et al.
Publicado: (2014)

Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder
por: Nishimori, Tomohiro, et al.
Publicado: (2021)

Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma
por: Kotoh, Yurika, et al.
Publicado: (2020)

Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment
por: Nakashima, Kei, et al.
Publicado: (2020)

Improved Hepatic Reserve and Fibrosis in a Case of “Portal-Systemic Liver Failure” by Portosystemic Shunt Occlusion
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2020)

Assessment of high-fat-diet-induced fatty liver in medaka
por: Fujisawa, Koichi, et al.
Publicado: (2018)

Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab
por: Taki, Takahiro, et al.
Publicado: (2020)

Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
por: Ahmed, Faiza, et al.
Publicado: (2021)

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
por: Iwamoto, Hideki, et al.
Publicado: (2022)

Real-Time Analysis of Isoprene in Breath by Using Ultraviolet-Absorption Spectroscopy with a Hollow Optical Fiber Gas Cell
por: Iwata, Takuro, et al.
Publicado: (2016)

Altered properties of amyloidogenic prion protein in genetic Creutzfeldt–Jakob disease with PRNP V180I mutation in response to pentosan polysulfate
por: Shijo, Masahiro, et al.
Publicado: (2023)

Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma
por: Ikeda, Munehiro, et al.
Publicado: (2022)

Two Cases of Atezolizumab-Induced Hypophysitis
por: Kanie, Keitaro, et al.
Publicado: (2017)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Lambert, Nicolas, et al.
Publicado: (2022)

Draft Genome Sequences of Streptomyces scabiei S58, Streptomyces turgidiscabies T45, and Streptomyces acidiscabies a10, the Pathogens of Potato Common Scab, Isolated in Japan
por: Tomihama, Tsuyoshi, et al.
Publicado: (2016)

Therapeutic Strategy Using Interventional Radiology for Refractory Esophageal Varices Resistant to Endoscopic Treatment
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2021)

Implications of Systemic Inflammation and Periodontitis for Major Depression
por: Hashioka, Sadayuki, et al.
Publicado: (2018)

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience
por: Hiraoka, Atsushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9g3futgk8n09qbfv5sipha2c84